Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Breast Neoplasms 53Neoplasms 36Colorectal Neoplasms 35Carcinoma, Non-Small-Cell Lung 33Prostatic Neoplasms 32Lung Neoplasms 30Pancreatic Neoplasms 22Multiple Myeloma 16Recurrence 15Ovarian Neoplasms 15Uterine Cervical Neoplasms 12Carcinoma, Hepatocellular 12Leukemia, Myeloid, Acute 11Neoplasm Metastasis 10Melanoma 10Head and Neck Neoplasms 10Brain Neoplasms 10Squamous Cell Carcinoma of Head and Neck 9Advanced Solid Tumors 9Stomach Neoplasms 8Rectal Neoplasms 8Glioblastoma 8Triple Negative Breast Neoplasms 7Small Cell Lung Carcinoma 7Endometrial Neoplasms 7Colonic Neoplasms 7Carcinoma, Renal Cell 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Lymphoma, B-Cell 6Glioma 6

Interventions

vedolizumab 1Photopheresis 1Mycophenolic Acid 1Methoxsalen 1Infliximab 1Azathioprine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Colitis × 30 days × Clear all
NCT07619898 2026-06-02

PHOENIX-ECP

Therakos LLC

Phase 2 Not yet recruiting
112 enrolled
Dermatologic

Colitis, Hepatitis, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡